Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula

被引:91
作者
Lee, Timmy
Barker, Jill
Allon, Michael
机构
[1] Univ Alabama, Div Nephrol, Birmingham, AL 35294 USA
[2] Dept Vet Affairs Med Ctr, Birmingham, AL USA
[3] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 06期
关键词
D O I
10.1681/ASN.2006101119
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although arteriovenous fistulas are considered superior to grafts, it is unknown whether that is true in the subset of patients with a previous failed fistula. For investigation of this question, a prospective vascular access database was queried retrospectively to compare the outcomes of 59 fistulas and 51 grafts that were placed in the upper arm after primary failure of an initial forearm fistula. Primary access failure was higher for subsequent fistulas than for subsequent grafts (44 versus 20%; P = 0.006). Fistulas required more interventions than grafts before their successful use (0.42 versus 0.16 per patient; P = 0.04). The time to catheter-free dialysis was longer for fistulas than for grafts (131 versus 34 d; P < 0.0001) and was associated with more episodes of bacteremia before permanent access use (1.3 versus 0.4 per patient; P = 0.003). Cumulative survival (from placement to permanent failure) was higher for fistulas than for grafts when primary failures were excluded (hazard ratio 0.51; 95% confidence interval 0.27 to 0.94; P = 0.03), but similar when primary failures were included (hazard ratio 0.99; 95% confidence interval 0.61 to 1.62; P = 0.97). Fistulas required fewer interventions to maintain long-term patency for dialysis after maturation (0.73 versus 2.38 per year; P < 0.001). In conclusion, as compared with grafts, subsequent upper arm fistulas are associated with a higher primary failure rate, more interventions to achieve maturation, longer catheter dependence, and more frequent catheter-related bacteremia. However, once the access is usable for dialysis, fistulas have superior cumulative patency than do grafts and require fewer interventions to maintain patency.
引用
收藏
页码:1936 / 1941
页数:6
相关论文
共 26 条
[1]   Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions [J].
Allon, M ;
Robbin, ML .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1109-1124
[2]   Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients [J].
Allon, M ;
Lockhart, ME ;
Lilly, RZ ;
Gallichio, MH ;
Young, CT ;
Barker, J ;
Deierhoi, MH ;
Robbin, ML .
KIDNEY INTERNATIONAL, 2001, 60 (05) :2013-2020
[3]   A multidisciplinary approach to hemodialysis access: Prospective evaluation [J].
Allon, M ;
Bailey, R ;
Ballard, R ;
Deierhoi, MH ;
Hamrick, K ;
Oser, R ;
Rhynes, VK ;
Robbin, ML ;
Saddekni, S ;
Zeigler, ST .
KIDNEY INTERNATIONAL, 1998, 53 (02) :473-479
[4]   Why don't fistulas mature? [J].
Dixon, B. S. .
KIDNEY INTERNATIONAL, 2006, 70 (08) :1413-1422
[5]   Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula [J].
Dixon, BS ;
Novak, L ;
Fangman, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (01) :92-101
[6]   Assessment of a policy to reduce placement of prosthetic hemodialysis access [J].
Gibson, KD ;
Caps, MT ;
Kohler, TR ;
Hatsukami, TS ;
Gillen, DL ;
Aldassy, M ;
Sherrard, DJ ;
Stehman-Breen, CO .
KIDNEY INTERNATIONAL, 2001, 59 (06) :2335-2345
[7]   Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake? [J].
Heine, GH ;
Ulrich, C ;
Köhler, H ;
Girndt, M .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (04) :461-468
[8]   Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis patients [J].
Heine, GH ;
Ulrich, C ;
Sester, U ;
Sester, M ;
Köhler, H ;
Girndt, M .
KIDNEY INTERNATIONAL, 2003, 64 (03) :1101-1107
[9]   Longitudinal comparison of dialysis access methods: Risk factors for failure [J].
Hodges, TC ;
Fillinger, MF ;
Zwolak, RM ;
Walsh, DB ;
Bech, F ;
Cronenwett, JL .
JOURNAL OF VASCULAR SURGERY, 1997, 26 (06) :1009-1019
[10]   Natriuretic peptides in ESRD [J].
Joffy, S ;
Rosner, MH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :1-10